# Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma

> **NCT01703507** · PHASE1 · COMPLETED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University** · enrollment: 17 (actual)

## Conditions studied

- Recurrent Melanoma
- Stage IV Melanoma
- Tumors Metastatic to Brain

## Interventions

- **DRUG:** Ipilimumab
- **RADIATION:** Whole-Brain Radiation Therapy (WBRT)
- **RADIATION:** Stereotactic Radiosurgery (SRS)

## Key facts

- **NCT ID:** NCT01703507
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11-09
- **Primary completion:** 2015-05-20
- **Final completion:** 2018-04-11
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2025-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01703507

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01703507, "Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01703507. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*